XML 82 R64.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue - Summary of Sales by Product Categories (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]    
Total $ 105,757 $ 113,450
Sales of Pharmaceutical Products    
Disaggregation of Revenue [Line Items]    
Total $ 105,757 $ 113,450